Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 175 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Modifying PEST for Psoriatic Arthritis Screening

Plaque Psoriasis, Psoriatic Arthritis Na Canada

LATAM LOWERS LDL-C

Hypercholesterolaemia Phase4 Argentina
Brazil

Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa Phase3 Argentina
Austria
Belgium
Canada
Colombia
Czechia
France
Germany
Greece
Hungary
Malaysia
Poland
Puerto Rico
Romania
Spain
Turkey (Türkiye)
United Kingdom
United States
View all

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis Phase3 Australia
Belgium
Canada
China
France
India
Japan
Poland
Romania
South Korea
Spain
Taiwan
United States
View all

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

Chronic Myeloid Leukemia (CML) Phase2 France

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Familial Hypercholesterolemia - Homozygous Phase3 Austria
China
Germany
Greece
Malaysia
Netherlands
South Africa
Taiwan
Turkey (Türkiye)
United Kingdom
United States
View all

A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence

Breast Neoplasms Austria
Germany

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

Dengue Phase2 Brazil
Colombia
India
Malaysia
Singapore
Vietnam
View all

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Prostate Cancer Phase2, Phase3 Australia
Brazil
China
Israel
Japan
Singapore
South Korea
Taiwan
United States
View all

Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)

Progressive Multiple Sclerosis Phase1, Phase2 Australia
Canada
France
Germany
Italy
Spain
Switzerland
View all